[2-[(3-fluorophenyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone
C18H17FN4O2S — CID 142540171
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-[(3-fluorophenyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone
[2-[(3-fluorophenyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone (PubChem CID 142540171) has the molecular formula C18H17FN4O2S and a molecular weight of 372.43 g/mol. Its IUPAC name is [2-[(3-fluorophenyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone.
Molecular Properties
| Compound Name | [2-[(3-fluorophenyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone |
|---|---|
| PubChem CID | 142540171 |
| Molecular Formula | C18H17FN4O2S |
| Molecular Weight | 372.43 g/mol |
| Exact Mass | 372.11 |
| IUPAC Name | [2-[(3-fluorophenyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone |
| SMILES | O=C(c1nc(NCc2cccc(F)c2)nc2ccsc12)N1CC[C@@H](O)C1 |
| InChI | InChI=1S/C18H17FN4O2S/c19-12-3-1-2-11(8-12)9-20-18-21-14-5-7-26-16(14)15(22-18)17(25)23-6-4-13(24)10-23/h1-3,5,7-8,13,24H,4,6,9-10H2,(H,20,21,22)/t13-/m1/s1 |
| InChIKey | SGPLNASMVXAYIT-CYBMUJFWSA-N |
| XLogP | 2.65 |
| TPSA | 78.35 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 372.43 |
| LogP ≤ 5 | 2.65 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142540171 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.